                         SEQUENCE LISTING

<110>  Institut Curie et al
 
<120>  New anti-LSP1 antibody

<130>  B2338PC

<160>  8     

<170>  PatentIn version 3.5

<210>  1
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  CDR1

<400>  1

Arg Thr Ser Tyr His Asp Asn 
1               5           


<210>  2
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  CDR2

<400>  2

Arg Tyr Ala Asn Thr Lys Ser 
1               5           


<210>  3
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  CDR3

<400>  3

Tyr Gly Pro Val Gly Trp Trp Arg Gly Gly Thr Pro 
1               5                   10          


<210>  4
<211>  28
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  FR1

<400>  4

Met Ala Glu Val Gln Leu Gln Ala Ser Gly Gly Gly Phe Val Gln Pro 
1               5                   10                  15      


Gly Gly Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly 
            20                  25              


<210>  5
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  FR2

<400>  5

Met Gly Trp Phe Arg Gln Ala Pro Gly Lys Glu Arg Glu Phe Val Ser 
1               5                   10                  15      


Ala Ile Ser 
            


<210>  6
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  FR3

<400>  6

Tyr Tyr Ala Asp Ser Val Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn 
1               5                   10                  15      


Ser Lys Asn Thr Val Tyr Leu Gln Met Asn Ser Leu Arg Ala Glu Asp 
            20                  25                  30          


Thr Ala Thr Tyr Tyr Cys Ala 
        35                  


<210>  7
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  FR4

<400>  7

Tyr Trp Gly Gln Gly Thr Gln Val Thr Val Ser Ser 
1               5                   10          


<210>  8
<211>  124
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Antibody D4

<400>  8

Met Ala Glu Val Gln Leu Gln Ala Ser Gly Gly Gly Phe Val Gln Pro 
1               5                   10                  15      


Gly Gly Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Arg Thr Ser Tyr 
            20                  25                  30          


His Asp Asn Met Gly Trp Phe Arg Gln Ala Pro Gly Lys Glu Arg Glu 
        35                  40                  45              


Phe Val Ser Ala Ile Ser Arg Tyr Ala Asn Thr Lys Ser Tyr Tyr Ala 
    50                  55                  60                  


Asp Ser Val Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn 
65                  70                  75                  80  


Thr Val Tyr Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Thr 
                85                  90                  95      


Tyr Tyr Cys Ala Tyr Gly Pro Val Gly Trp Trp Arg Gly Gly Thr Pro 
            100                 105                 110         


Tyr Trp Gly Gln Gly Thr Gln Val Thr Val Ser Ser 
        115                 120                 


